Cargando…
Effectiveness of the Pfizer-BioNTech Vaccine against COVID-19-Associated Hospitalizations among Lebanese Adults ≥75 Years Old—Lebanon, April–May 2021
In Lebanon, the nationwide vaccination against COVID-19 was launched in February 2021 using the Pfizer-BioNTech vaccine and prioritizing elderly people, persons with comorbidities, and healthcare workers. Our study aims to estimate the post-introduction vaccine effectiveness (VE) of the Pfizer-BioNT...
Autores principales: | Farah, Zeina, Haddad, Nadine, Abou El Naja, Hala, Saleh, Majd, Mrad, Pamela, Ghosn, Nada |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10297521/ https://www.ncbi.nlm.nih.gov/pubmed/37367187 http://dx.doi.org/10.3390/epidemiologia4020022 |
Ejemplares similares
-
Calculating the serial interval of SARS-CoV-2 in Lebanon using 2020 contact-tracing data
por: Haddad, Nadine, et al.
Publicado: (2021) -
Communicable Disease Surveillance in Lebanon during the Syrian Humanitarian Crisis, 2013–2019
por: Farah, Zeina, et al.
Publicado: (2023) -
Estimation of the influenza‐associated respiratory hospitalization burden using sentinel surveillance data, Lebanon, 2015–2020
por: Farah, Zeina, et al.
Publicado: (2023) -
Experience of field testing in Lebanon during the COVID-19 pandemic, January to August 2021
por: Farah, Zeina, et al.
Publicado: (2022) -
Myocarditis with Pfizer-BioNTech's COVID-19 vaccine in Israel
Publicado: (2021)